CytoDyn Inc. General form for registration of securities under the Securities Act of 1933

General form for registration of securities under the Securities Act of 1933

(Loss) Income per Share (Tables)

(Loss) Income per Share (Tables)

9 Months Ended

12 Months Ended

Feb. 28, 2026

May 31, 2025

(Loss) Income per Share

Schedule of reconciliation of the numerators and denominators of basic and diluted net (loss) income per share


		Nine months ended February 28,
(in thousands, except per share amounts)		2026			2025
Numerator:
Net (loss) income		$	(32,837)		$	9,701
Less: Accrued preferred stock dividends			(1,106)			(1,106)
Basic net (loss) income applicable to common stockholders			(33,943)			8,595
Diluted net (loss) income applicable to common stockholders		$	(33,943)		$	8,595

Denominator:
Basic weighted average common shares outstanding			1,262,834			1,194,561
Effect of dilutive securities:
Warrant exercises			—			30,352
Preferred stock conversions			—			625
Diluted weighted average common shares outstanding			1,262,834			1,225,538

Basic (loss) income per share		$	(0.03)		$	0.01
Diluted (loss) income per share		$	(0.03)		$	0.01


		Years ended May 31,
(in thousands, except per share amounts)		2025			2024
Numerator:
Net income (loss)		$	3,745		$	(49,841)
Less: Accrued preferred stock dividends			(1,483)			(1,483)
Net income (loss) applicable to common stockholders		$	2,261		$	(51,324)
Denominator:
Basic weighted average common shares outstanding			1,205,755			969,509
Effect of dilutive securities:
Warrant exercises			34,821			—
Option exercises			2,346			—
Diluted weighted average common shares outstanding			1,242,922			969,509

Basic income (loss) per share			0.00			(0.05)
Diluted income (loss) per share			0.00			(0.05)

Schedule of securities excluded from computation of earnings per share


	nine months ended February 28,
(in thousands)	2026		2025
Stock options, PSUs, and warrants	341,956		231,027
Convertible notes	12,000		12,000
Convertible preferred stock	42,232		39,265


	Years ended, May 31
(in thousands)	2025		2024
Stock options, PSUs, and warrants	217,785		387,294
Convertible notes	12,000		12,000
Convertible preferred stock	40,013		37,046